Creative Medical Technology Holdings Inc (CELZ) Stock Analysis

Creative Medical Technology Holdings Inc (CELZ) is a publicly traded company in the HEALTHCARE sector. It trades at $2.25, carries a market capitalization of $8.32M. This page summarizes the public market data, fundamentals, and frequently asked questions for CELZ, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Creative Medical Technology Holdings Inc currently has a Neutral sentiment score of -0.07.

About Creative Medical Technology Holdings Inc

Creative Medical Technology Holdings, Inc. (CELZ) is an innovative biotechnology company headquartered in Phoenix, Arizona, dedicated to advancing regenerative medicine through the development of cutting-edge adult stem cell therapies. The firm concentrates on critical sectors such as immunology, urology, orthopedics, and neurology, targeting unmet medical needs and striving to enhance patient outcomes. With a robust research pipeline and a commitment to leveraging the unique properties of st...

GNG Research Analysis

GNG Research scores Creative Medical Technology Holdings Inc (CELZ) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CELZ.

Frequently Asked Questions

Does CELZ pay dividends?

Creative Medical Technology Holdings Inc (CELZ) does not currently pay a regular dividend.

What is CELZ's market cap?

Creative Medical Technology Holdings Inc (CELZ) has a market capitalization of $8.32M with a current stock price of $2.25.